Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 6Phase 1/2 5Phase 3 4Phase NA 2Phase 4 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Carcinoma, Renal Cell 20Gastrointestinal Stromal Tumors 9Kidney Neoplasms 6Breast Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Kidney Diseases 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Urologic Neoplasms 1Prostatic Neoplasms 1Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 1Patient Preference 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms by Site 1Gastrointestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Colorectal Neoplasms 1Carcinoma, Islet Cell 1Carcinoma, Hepatocellular 1Carcinoid Tumor 1Advanced Renal Cancer 1Adenoma, Islet Cell 1

Interventions

Cyclophosphamide 149Docetaxel 139Paclitaxel 127Trastuzumab 120Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Sunitinib × Clear all
NCT00373256 2012-09-10

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Pfizer

Phase 3 Completed
488 enrolled 12 charts
Breast

Breast Neoplasms

NCT00393939 2012-07-19

SUN 1064

Pfizer

Phase 3 Completed
594 enrolled 11 charts
Breast

Breast Neoplasms

NCT00435409 2012-06-26

A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer

Pfizer

Phase 3 Completed
442 enrolled 12 charts
Breast

Breast Neoplasms

NCT00373113 2012-06-25

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine

Pfizer

Phase 3 Terminated
482 enrolled 12 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡